# Phase II Study of Gamma Knife Radiosurgery and Temozolomide for Brain Metastases

> **NCT00582075** · PHASE2 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 25 (actual)

## Conditions studied

- Cancer
- Brain Metastases

## Interventions

- **DRUG:** temozolomide

## Key facts

- **NCT ID:** NCT00582075
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** 2008-10
- **Final completion:** 2015-06
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2023-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00582075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00582075, "Phase II Study of Gamma Knife Radiosurgery and Temozolomide for Brain Metastases". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00582075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*